Starling Surgical logo — The only wound closure device, as fast as a skin stapler, wi...

Starling Surgical

The only wound closure device, as fast as a skin stapler, with all the clinical advantages of meticulous sutures.

Founded 2017 Ireland Ireland 1 employees Seed Health Care

General Information

Company Name Starling Surgical
Founded Year 2017
Location Ireland Ireland +1
Employees 1
Industries Health Care
Funding Stage Seed
Social

Get notified when Starling Surgical moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Starling Surgical

Starling Surgical, founded in 2017 and headquartered in Ireland, is a health care startup aiming to revolutionize wound closure technology. Their flagship product, the Quickstitch, boasts being the only wound closure device that offers the clinical benefits of sutures while operating at the speed of a skin stapler. This innovation has attracted the attention of MedTech Innovator, who led the Seed Round investment in the company on 17 June 2019. The company's slogan encapsulates their mission to provide optimal wound closure every time, promising patients a finer scar post-operation. Starling Surgical's commitment is evidenced by their continuous development, testing, and iterations to ensure the Quickstitch delivers exceptional results. Their focus on user experience is highlighted by the device's intuitiveness and simplicity, earning accolades from users. In the competitive health care industry, Starling Surgical's dedication to enhancing patient outcomes through innovative technology positions them as a promising investment opportunity. The recent backing from MedTech Innovator underscores their potential to disrupt the wound closure market and signifies confidence in the Quickstitch's capabilities.

Taxonomy: wound closure device, surgical technology, medical innovation, clinical advantages, wound closure, sutures, surgical equipment, patient outcomes, medical devices industry, startup, innovation, surgical procedures, medical devices innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
17 Jun 2019

Starling Surgical Alternatives & Competitors

Starling Surgical vs
microMend®
microMend® United States

Designed to replace sutures and staples, microMend PRO devices are the ideal solution for healthcare...

Series B
11 employees
Biotechnology, Health Care
Starling Surgical vs
DermaClip US, LLC
DermaClip US, LLC United States

A new wound closure paradigm. The DermaClip non-invasive device replaces sutures, staples and glues...

5 employees
Starling Surgical vs
Corporis Medical
Corporis Medical The Netherlands

Corporis Medical focuses on the development and commercialization of innovative surgical devices.

Series B
16 employees
Medical Devices

FAQ About Starling Surgical

The only wound closure device, as fast as a skin stapler, with all the clinical advantages of meticulous sutures.
Starling Surgical was founded in 2017.
Starling Surgical is headquartered in Ireland.
Starling Surgical operates in the following industries: Health Care.
Starling Surgical has approximately 1 employees.
Starling Surgical has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Starling Surgical include microMend®, DermaClip US, LLC, Corporis Medical , RenovoDerm, Vivasure Medical Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Starling Surgical and microMend® are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Starling Surgical and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy